Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06828497Not ApplicableCompleted

Analgesic Efficacy of Quadratus Lumborum Block Against Erector Spinae Plane Block in Laparoscopic Sleeve Gastrectomy

Role: lead

NCT06745986Phase 4Completed

Ultrasound-Guided Fascia Iliaca Compartmental Block Versus Spinal Anesthesia in Femoral Thrombectomy

Role: lead

NCT04507191Completed

PDL1 in Ovarian High Grade Serous Carcinoma

Role: lead

NCT04284631Completed

Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.

Role: lead

NCT04313218Completed

Carbetocin Versus Misoprostol. A Retrospective Comparative Study

Role: lead

All 5 trials loaded